{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:49:08Z","timestamp":1782254948957,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd013210","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000}}],"reference-count":163,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013210.pub2","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T14:47:40Z","timestamp":1568299660000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Interventions for maintenance of surgically induced remission in Crohn\u2019s disease: a network meta-analysis"],"prefix":"10.1002","volume":"2019","author":[{"given":"Zipporah","family":"Iheozor-Ejiofor","sequence":"first","affiliation":[{"name":"University of Central Lancashire; School of Medicine; Harrington Building Preston Lancashire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"University of Central Lancashire; School of Medicine; Harrington Building Preston Lancashire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clegg","sequence":"additional","affiliation":[{"name":"University of Central Lancashire; Faculty of Health and Wellbeing; Brook Building Victoria Street Preston Lancashire UK PR1 2HE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C","family":"Freeman","sequence":"additional","affiliation":[{"name":"University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuta","family":"Gjuladin-Hellon","sequence":"additional","affiliation":[{"name":"University of Central Lancashire; School of Medicine; Harrington Building Preston Lancashire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"University of Western Ontario; Department of Medicine; London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Sidra Medicine; PO Box 26999 Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2004.06.051","article-title":"Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease","volume":"127","author":"Ardizzone","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013210.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S780","DOI":"10.1016\/S0016-5085(12)63025-X","article-title":"Prevention of postoperative recurrence with azathioprine or anti-TNF alpha in patients with Crohn's disease: an open-label pilot study","volume":"142","author":"Armuzzi","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD013210.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.crohns.2013.04.020","article-title":"Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study","volume":"7","author":"Armuzzi","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"7","key":"10.1002\/14651858.CD013210.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/00365521.1976.12097167","article-title":"Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease","volume":"11","author":"Bergman","year":"1976","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0016-5085(95)90059-4","article-title":"Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease","volume":"108","author":"Brignola","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.1994.tb00158.x","article-title":"Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease","volume":"8","author":"Caprilli","year":"1994","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2036.2003.01462.x","article-title":"Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial","volume":"17","author":"Caprilli","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10620-006-9549-7","article-title":"Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease","volume":"52","author":"Chermesh","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2008.07.010","article-title":"Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's Disease: a controlled randomized trial","volume":"135","author":"D'Haens","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000199850","article-title":"Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial","volume":"42","author":"Ewe","year":"1989","journal-title":"Digestion"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00042737-199903000-00011","article-title":"Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial","volume":"11","author":"Ewe","year":"1999","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0012|cit12","first-page":"928","article-title":"The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease","volume":"13","author":"Fedorak","year":"2015","journal-title":"Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0013|cit13","unstructured":"NCT00175292 A randomized controlled trial of VSL#3 for the prevention of endoscopic recurrence following surgery for Crohn's clinicaltrials.gov\/ct2\/show\/NCT00175292"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00042737-199603000-00008","article-title":"Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease","volume":"8","author":"Florent","year":"1996","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD013210.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00595-018-1627-x","article-title":"Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan","volume":"48","author":"Fukushima","year":"2018","journal-title":"Surgery Today"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0016|cit16","unstructured":"JPRN-UMIN000002604 Combined therapy of infliximab with surgery in maintenance of remission in Crohn's disease upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000003157"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ibd.20063","article-title":"Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection","volume":"13","author":"Gossum","year":"2007","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.ebg.0000154100.00152.9f","article-title":"Can we prevent the inevitable? The use of 6-mercaptopurine or mesalamine to prevent postoperative recurrence in patients with Crohn disease","volume":"6","author":"Hanauer","year":"2005","journal-title":"Evidence-Based Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","article-title":"Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial","volume":"127","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0016-5085(99)70125-3","article-title":"Oral budesonide for prevention of postsurgical recurrence in Crohn's disease","volume":"116","author":"Hellers","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0021|cit21","unstructured":"Herfarth H Obermeier F Tjaden C Lukas M Serclova Z Dignass AU Double-blind, double dummy, randomized, multicentre, comparative study on the efficacy and safety of azathioprine (AZA) versus mesalazine (5-ASA) for prevention of postoperative endoscopic recurrence in Crohn\u2019s disease Gastroenterology 2006 A480 1"},{"issue":"10","key":"10.1002\/14651858.CD013210.pub2-BIB0022|cit22","first-page":"1525","article-title":"Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease","volume":"55","author":"Herfarth","year":"2006","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0023|cit23","unstructured":"Muller R Herfarth H More information on study in 2006 Gut [personal communication] Email to: M Gordon"},{"issue":"5","key":"10.1002\/14651858.CD013210.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/01.MIB.0000428910.36091.10","article-title":"Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study","volume":"19","author":"Herfarth","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0025|cit25","unstructured":"NCT00609973 Ciprofloxacin for the prevention of postoperative endoscopic recurrence in Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT00609973"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0016-5085(00)70208-3","article-title":"Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI","volume":"118","author":"Lochs","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0027|cit27","first-page":"A3","article-title":"APPRECIA: adalimumab vs azathioprine in the prevention of Crohn's disease recurrence after surgical resection. A GETECCU multicenter randomized trial","volume":"1","author":"Lopez-Sanroman","year":"2015","journal-title":"United European Gastroenterology Journal"},{"issue":"11","key":"10.1002\/14651858.CD013210.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/ecco-jcc\/jjx051","article-title":"Adalimumab vs azathioprine in the prevention of postoperative Crohn\u2019s disease recurrence. A GETECCU randomised trial","volume":"11","author":"Lopez-Sanroman","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0029|cit29","unstructured":"NCT01564823 Adalimumab on preventing post-chirurgic recurrence on Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT01564823"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1016\/S0016-5085(16)31536-0","article-title":"Health-related quality of life improves during one year of postoperative prophylactic drug therapy after ileocecal intestinal resection in Crohn's disease patients: results of the APPRECIA randomized trial","volume":"1","author":"Taxonera","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0032|cit31","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S1873-9946(12)60230-X","article-title":"Azathioprine versus azathioprine plus metronidazole for the prevention of postoperative endoscopic recurrence of Crohn's disease: a randomized, placebo-controlled trial","volume":"1","author":"Manosa","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"9","key":"10.1002\/14651858.CD013210.pub2-BIB0031|cit32","first-page":"1889","article-title":"Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Ma\u00f1osa","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1002\/14651858.CD013210.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","article-title":"Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial","volume":"55","author":"Marteau","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0016-5085(95)90327-5","article-title":"Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease","volume":"109","author":"McLeod","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"A43","DOI":"10.1136\/gutjnl-2016-312388.71","article-title":"The TOPPIC trial: a randomised, double-blind parallel group trial of mercaptopurine vs placebo to prevent recurrence of Crohn's disease following surgical resection in 240 patients","volume":"65","author":"Arnott","year":"2016","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0036|cit36","unstructured":"ISRCTN89489788 Randomised controlled trial of 6-Mercaptopurine (6MP) versus placebo to prevent recurrence of Crohn's disease following surgical resection isrctn.com\/ISRCTN89489788"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2468-1253(16)30078-4","article-title":"Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Mowat","year":"2016","journal-title":"Lancet Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.51.3.405","article-title":"Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG","volume":"51","author":"Prantera","year":"2002","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0039|cit39","unstructured":"NCT00688636 Infliximab for the prevention of recurrent Crohn's disease after surgery clinicaltrials.gov\/ct2\/show\/NCT00688636"},{"issue":"12","key":"10.1002\/14651858.CD013210.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1007\/s10620-011-1785-9","article-title":"Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease","volume":"56","author":"Regueiro","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","article-title":"Infliximab prevents Crohn's disease recurrence after ileal resection","volume":"136","author":"Regueiro","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0042|cit42","unstructured":"EUCTR2010-018431-18-DE A multicenter trial comparing REMICADE (infliximab) and placebo in the prevention of recurrence in Crohn's disease patients undergoing surgical resection who are at an increased risk of recurrence clinicaltrialsregister.eu\/ctr-search\/trial\/2010-018431-18\/GB"},{"issue":"7","key":"10.1002\/14651858.CD013210.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2016.02.072","article-title":"Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease after ileocolonic resection","volume":"150","author":"Regueiro","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013210.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.2009.194159","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial","volume":"59","author":"Reinisch","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/S1873-9946(13)60629-7","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial","volume":"7","author":"Reinisch","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","article-title":"Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Rutgeerts","year":"2005","journal-title":"Gastroenterology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013210.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"S774","DOI":"10.1016\/S0016-5085(17)32685-9","article-title":"Adalimumab therapy rather than azathioprine and mesalamine is able to halt Crohn's disease progression after resective surgery and a post-hoc analysis of a prospective randomized study","volume":"152","author":"Bodini","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/ajg.2013.287","article-title":"Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial","volume":"108","author":"Savarino","year":"2013","journal-title":"American Journal of Gastroenterology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD013210.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/S0016-5085(15)30790-3","article-title":"Early initiation of adalimumab significantly diminishes post-operative Crohn's disease recurrence, and is superior to immunomodulator therapy. Preliminary results from the POPART trial","volume":"148","author":"Scapa","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0016-5085(97)70117-3","article-title":"A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group","volume":"112","author":"Sutherland","year":"1997","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD013210.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10151-014-1177-1","article-title":"Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study","volume":"18","author":"Tursi","year":"2014","journal-title":"Techniques in Coloproctology"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00365527809181743","article-title":"The long-term 20 prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with 21 Crohn's disease. A controlled double-blind trial","volume":"13","author":"Wenckert","year":"1978","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013210.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/ibd.21928","article-title":"Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial","volume":"18","author":"Yoshida","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MIB.0b013e31827eea8b","article-title":"Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels","volume":"19","author":"Angelberger","year":"2013","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S856","DOI":"10.1016\/S0016-5085(15)32901-2","article-title":"Infliximab is more effective than azathioprine in the long-term prevention of postoperative recurrence of Crohn's disease","volume":"148","author":"Armuzzi","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0056|cit56","first-page":"102","article-title":"Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study: Commentary","volume":"10","author":"Balzola","year":"2010","journal-title":"Inflammatory Bowel Disease Monitor"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.12831","article-title":"Letter: Biological therapies are effective for prevention of post-operative Crohn's disease recurrence","volume":"40","author":"Bodini","year":"2014","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD013210.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.dld.2014.07.171","article-title":"Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab","volume":"46","author":"Bodini","year":"2014","journal-title":"Digestive and Liver Disease"},{"issue":"10","key":"10.1002\/14651858.CD013210.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.cgh.2015.01.018","article-title":"Anti-tumor necrosis factor antibodies for prevention of Crohn's disease recurrence after surgery: more than a hope","volume":"13","author":"Bodini","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0399-8320(05)80774-2","article-title":"Efficacy of azathioprine and its derivative, 6-mercaptopurine in the prevention of post operative recurrent Crohn's disease","volume":"29","author":"Bourreille","year":"2005","journal-title":"Gastroent\u00e9rologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0061|cit61","first-page":"100","article-title":"Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study","volume":"4","author":"Cruz","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013210.pub2-BIB0062|cit62","first-page":"92","article-title":"Strategic timing of anti-TNF therapy in postoperative Crohn's disease: comparison of routine use immediately postoperatively with selective use after demonstrated recurrence at 6 month endoscopy. Results from POCER","volume":"28","author":"Cruz","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0063|cit63","first-page":"A95","article-title":"Smoking is the key risk factor that doubles the risk of postoperative recurrence of Crohn's disease despite preventive drug treatment. Results from the POCER study","volume":"1","author":"Cruz","year":"2013","journal-title":"United European Gastroenterology Journal"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0064|cit64","first-page":"A16","article-title":"Strategic timing of anti-TNF therapy in postoperative Crohn's disease: comparison of routine use immediately postoperatively with selective use after demonstrated recurrence at 6 month endoscopy: results from POCER","volume":"1","author":"Cruz","year":"2013","journal-title":"United European Gastroenterology Journal"},{"issue":"7","key":"10.1002\/14651858.CD013210.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/apt.13353","article-title":"Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis","volume":"42","author":"Cruz","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9976","key":"10.1002\/14651858.CD013210.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","article-title":"Crohn's disease management after intestinal resection: a randomised trial","volume":"385","author":"Cruz","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD013210.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/ibd.20973","article-title":"Targeting TNF in postoperative recurrence of Crohn's disease: can we extinguish the fire before it starts?","volume":"15","author":"Doherty","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0068|cit68","first-page":"249","article-title":"Can postoperative relapse of Crohn's disease be prevented?","volume":"96","author":"Dumois","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"Pt 1","key":"10.1002\/14651858.CD013210.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/978-3-642-85451-4_235","article-title":"Prophylaxis after resection because of Crohn\u2019s disease by Salazosulfapyridin (Azulfidine). A double-blind study","volume":"82","author":"Ewe","year":"1976","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Innere Medizin"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/978-3-642-47091-2_338","article-title":"Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study","volume":"86","author":"Ewe","year":"1980","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Innere Medizin"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0071|cit71","first-page":"41","article-title":"Effectiveness of Azulfidine\/Salazopyrin in the postoperative prevention of recurrence in Crohn disease","volume":"19","author":"Ewe","year":"1981","journal-title":"Zeitschrift fur Gastroenterologie - Verhandlungsband"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01823251","article-title":"Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study - initial results","volume":"364","author":"Ewe","year":"1984","journal-title":"Langenbecks Archiv fur Chirurgie"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013210.pub2-BIB0073|cit73","first-page":"S","article-title":"Systematic versus endoscopy-driven treatment with azathioprine to prevent postoperative ileal Crohn's disease recurrence: interim results from a randomized, multicenter trial","volume":"146","author":"Ferrante","year":"2014","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD013210.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2010.218941","article-title":"Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease","volume":"59","author":"Ford","year":"2010","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD013210.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.cgh.2014.02.014","article-title":"Anti-tumor necrosis factor therapy to prevent Crohn's disease recurrence after surgery","volume":"12","author":"Herfarth","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0076|cit76","first-page":"S164","article-title":"Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study","volume":"1","author":"Kamm","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1873-9946(14)60024-6","article-title":"Optimising post-operative Crohn's disease management: best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study","volume":"8","author":"Kamm","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/ecco-jcc\/jju027.426","article-title":"Interobserver agreement in assessment of Rutgeerts' score of endoscopic recurrence of ileal Crohn's disease: a substudy of the TOPPIC trial","volume":"9","author":"Kennedy","year":"2015","journal-title":"Journal of Crohn's and Colitis"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0079|cit79","first-page":"167","article-title":"Efficacy of polyglycosides of Tripterygium wilfordii in preventing postoperative recurrence of Crohn disease","volume":"12","author":"Liao","year":"2009","journal-title":"Chinese Journal of Gastrointestinal Surgery"},{"issue":"10","key":"10.1002\/14651858.CD013210.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.cgh.2015.01.024","article-title":"VSL#3 in postoperative Crohn's disease","volume":"13","author":"Manship","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.gastro.2004.11.035","article-title":"Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect? [3] (multiple letters)","volume":"128","author":"Mardini","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD013210.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0016-5085(97)70001-5","article-title":"Risk and significance of endoscopic\/radiological evidence of recurrent Crohn's disease","volume":"113","author":"McLeod","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0083|cit83","unstructured":"NCT00074542 An efficacy and safety study of Omega-3 free fatty acids (Epanova\u2122) for the maintenance of symptomatic remission in subjects with Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT00074542"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0084|cit84","unstructured":"NCT01190839 A multicenter trial comparing REMICADE (Infliximab) and placebo in the prevention of recurrence in Crohn's disease (CD) patients undergoing surgical resection who are at an increased risk of recurrence clinicaltrials.gov\/ct2\/show\/NCT01190839"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0085|cit85","unstructured":"NCT01696942 Cimzia versus mesalamine for Crohn's recurrence clinicaltrials.gov\/show\/NCT01696942"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0086|cit86","unstructured":"NCT02247258 Azathioprine in the prevention of ileal Crohn's disease postoperative recurrence clinicaltrials.gov\/ct2\/show\/NCT02247258"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0087|cit87","unstructured":"NCT02255370 Curcumin associated with thiopurin in the prevention of post-op recurrence in Crohn disease clinicaltrials.gov\/ct2\/show\/NCT02255370"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0088|cit88","unstructured":"NCT02997059 Effect of fluconazole on the levels of ASCA after surgical resection for Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT02997059"},{"issue":"9","key":"10.1002\/14651858.CD013210.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.crohns.2012.02.012","article-title":"Adalimumab for the prevention and\/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study","volume":"6","author":"Papamichael","year":"2012","journal-title":"Journal of Crohn's and Colitis"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013210.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0016-5085(13)60618-6","article-title":"Infliximab maintenance beyond one year prevents postoperative Crohn's disease recurrence: long-term follow-up from the randomized controlled pilot study","volume":"144","author":"Regueiro","year":"2013","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD013210.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.cgh.2013.12.035","article-title":"Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence","volume":"12","author":"Regueiro","year":"2014","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD013210.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00104-015-0094-9","article-title":"Optimal management of Crohn's disease after intestinal resection","volume":"86","author":"Reibetanz","year":"2015","journal-title":"Der Chirurg; Zeitschrift fur alle Gebiete der Operativen Medizen"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0300060512474744","article-title":"Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine","volume":"41","author":"Ren","year":"2013","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD013210.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2004.07.037","article-title":"The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain","volume":"127","author":"Sandborn","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD013210.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0895-4356(92)90098-8","article-title":"Application of a stopping rule based on total treatment failures: the postoperative Crohn's disease trial","volume":"45","author":"Steinhart","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD013210.pub2-BIB0096|cit96","first-page":"491","article-title":"Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease","volume":"12","author":"Tao","year":"2009","journal-title":"Chinese Journal of Gastrointestinal Surgery"},{"issue":"11","key":"10.1002\/14651858.CD013210.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/ecco-jcc\/jjx051","article-title":"Adalimumab vs azathioprine in the prevention of postoperative Crohn's disease recurrence. A GETECCU randomised trial","volume":"11","author":"Vera-Mendoza","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"S435","DOI":"10.1016\/S0016-5085(14)61564-X","article-title":"Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study","volume":"156","author":"Wright","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0099|cit99","first-page":"145","article-title":"Structured post-operative treatment and monitoring to prevent Crohn's disease recurrence is cost effective. Results from the POCER study","volume":"30","author":"Wright","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD013210.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/ibd.20915","article-title":"Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study","volume":"15","author":"Yamamoto","year":"2009","journal-title":"Inflammatory Bowel Diseases"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.crohns.2012.09.011","article-title":"Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease","volume":"7","author":"Yamamoto","year":"2013","journal-title":"Journal of Crohn's and Colitis"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.dld.2014.09.008","article-title":"Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial","volume":"47","author":"Zhu","year":"2015","journal-title":"Digestive and Liver Disease"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0103|cit103","unstructured":"NCT00976690 Comparison azathioprine to mesalazine for the prevention of postoperative recurrence in the Crohn Disease (IMURELPOST) clinicaltrials.gov\/ct2\/show\/NCT00976690"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0104|cit104","unstructured":"NCT01698970 Effect of the consumption of a probiotic strain on the prevention of post-operative recurrence in Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT01698970"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0105|cit105","unstructured":"EUCTR2015-000555-24-NL Randomized, placebo-controlled, double-blind, multicenter study to determine the effectiveness and safety of vedolizumab in prevention of recurrence of Crohn's disease of the mucosa in patients with surgical removal of the area between the small and the large bowel clinicaltrialsregister.eu\/ctr-search\/trial\/2015-000555-24\/NL"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0106|cit106","unstructured":"NCT01015391 Efficacy study of T2 versus AZA to maintain clinical and endoscopic remission in postoperative Crohn's disease clinicaltrials.gov\/show\/NCT01015391"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0107|cit107","unstructured":"NCT02834754 A randomized, double-blind, placebo controlled study of vedolizumab for the prevention of post-operative Crohn's disease recurrence clinicaltrials.gov\/show\/NCT02834754"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0108|cit108","unstructured":"NCT03185611 Effectiveness of rifaximin combined with thiopurine on preventing postoperative recurrence in Crohn's disease clinicaltrials.gov\/show\/NCT03185611"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0109|cit109","unstructured":"NCT03185624 Effectiveness of rifaximin on preventing postoperative recurrence in Crohn's disease clinicaltrials.gov\/ct2\/show\/NCT03185624"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0110|cit110","unstructured":"NCT03456752 Perioperative dexamethasone on postoperative outcome in IBD clinicaltrials.gov\/show\/NCT03456752"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0111|cit111","unstructured":"NL6213 (NTR6385) A trial to compare if the diseased area between the colon and the small bowel of patients with Crohn's disease stays free of disease after surgery between a group of patients whom receive no medication versus a group whom receive vedolizumab https:\/\/www.trialregister.nl\/trial\/6213"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/sim.5539","article-title":"Extending methods for investigating the relationship between treatment effect and baseline risk for pairwise meta-analysis to network meta-analysis","volume":"32","author":"Achana","year":"2013","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013210.pub2-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003715.pub3","article-title":"Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease","author":"Akobeng","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0114|cit114","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006893","article-title":"Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease","author":"Behm","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","article-title":"Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease","volume":"231","author":"Bernell","year":"2000","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0116|cit116","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"issue":"10","key":"10.1002\/14651858.CD013210.pub2-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000067.pub3","article-title":"Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease","author":"Chande","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0118|cit118","unstructured":"Institute of Social and Preventive Medicine University of Bern CINeMA: Confidence in Network Meta-Analysis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0119|cit119","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0120|cit120","first-page":"362","article-title":"The role of leukopenia in the 6-mercaptopurine induced remission of refractory Crohn's disease","volume":"89","author":"Colonna","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/sim.3594","article-title":"Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation","volume":"28","author":"Cooper","year":"2009","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.v10.i10.1521","article-title":"Effects of probiotic on intestinal mucosa of patients with ulcerative colitis","volume":"15","author":"Cui","year":"2004","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157488631101160212171757","article-title":"Biologic drugs in Crohn's disease and ulcerative colitis: safety profile","volume":"11","author":"Sario","year":"2016","journal-title":"Current Drug Safety"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0124|cit124","first-page":"932","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistical Methodology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0125|cit125","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Egger","year":"2001"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0126|cit126","unstructured":"US Food Drug Administration Code of Federal Regulations Title 21.:21CFR312.32 https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=312.32"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"ECCO; 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: Part 2: Surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"issue":"6","key":"10.1002\/14651858.CD013210.pub2-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008414.pub3","article-title":"Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease","author":"Gjuladin-Hellon","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD013210.pub2-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010233.pub3","article-title":"Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease","author":"Gjuladin-Hellon","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0130|cit130","first-page":"598","article-title":"Risk factors for postoperative recurrence of Crohn\u2019s disease with emphasis on surgical predictors","volume":"30","author":"Gklavas","year":"2017","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD013210.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4292\/wjgpt.v8.i2.99","article-title":"5-aminosalicylates to maintain remission in Crohn\u2019s disease: interpreting conflicting systematic review evidence","volume":"8","author":"Gordon","year":"2017","journal-title":"World Journal of Gastrointestinal Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0132|cit132","unstructured":"McMaster University GRADEpro GDT: GRADEpro Guideline Development Tool 2015 (developed by Evidence Prime, Inc.)"},{"issue":"12","key":"10.1002\/14651858.CD013210.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6: rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0134|cit134","first-page":"17","article-title":"Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate [Le mycoph\u00e9nolate mof\u00e9til dans les formes chroniques actives de la maladie de Crohn apr\u00e8s \u00e9chec de lazathioprine ou du m\u00e9thotrexate]","volume":"26","author":"Hafraoui","year":"2002","journal-title":"Gastroenterologie Clinique et Biologique"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","article-title":"Management of Crohn\u2019s disease in adults","volume":"96","author":"Hanauer","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0136|cit136","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jval.2014.01.004","article-title":"Indirect treatment comparison\/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report","volume":"17","author":"Jansen","year":"2014","journal-title":"Value Health"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","article-title":"Developing a standard set of patient-centred outcomes for inflammatory bowel disease - an international, cross-disciplinary consensus","volume":"12","author":"Kim","year":"2017","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"Management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Statistics and Computing"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/ajg.2017.394","article-title":"Surgical rates for Crohn\u2019s disease are decreasing: a population-based time trend analysis and validation study","volume":"112","author":"Ma","year":"2017","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD013210.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","article-title":"Approaches to interpreting and choosing the best treatments in network meta-analyses","volume":"6","author":"Mbuagbaw","year":"2017","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013210.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/apt.12102","article-title":"NICE clinical guidelines (CG152): the management of Crohn's disease in adults, children and young people","volume":"37","author":"Mayberry","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0145|cit145","unstructured":"National Institute of Health and Care Excellence Crohn\u2019s disease: management [NG129] www.nice.org.uk\/guidance\/ng129\/evidence\/postsurgical-maintenance-of-remission-pdf-6777581006"},{"issue":"6","key":"10.1002\/14651858.CD013210.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012583.pub2","article-title":"Dressings and topical agents for treating venous leg ulcers","author":"Norman","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD013210.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.crohns.2014.02.010","article-title":"Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort","volume":"8","author":"Orlando","year":"2014","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0148|cit148","first-page":"2815","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistical Methodology"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0149|cit149","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/gut.51.2.152","article-title":"Crohn's disease recurrence can be prevented after ileal resection","volume":"51","author":"Rutgeerts","year":"2002","journal-title":"Gut"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0152|cit152","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0153|cit153","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"Journal of the Royal Statistical Society: Series B"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0155|cit155","volume-title":"Bayesian Approaches to Clinical Trials and Health-Care Evaluation","author":"Spiegelhalter","year":"2004"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0156|cit156","unstructured":"StataCorp LLC Stata Statistical Software 2017"},{"issue":"4","key":"10.1002\/14651858.CD013210.pub2-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000301","article-title":"Corticosteroids for maintenance of remission in Crohn's disease","author":"Steinhart","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0158|cit158","volume-title":"Methods for meta-analysis in medical research","author":"Sutton","year":"2000"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.0954-6820.1942.tb06841.x","article-title":"Salazopyrin, a new sulfanilamide preparation: A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulfanilamide preparation","volume":"110","author":"Svartz","year":"1942","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/sim.6131","article-title":"Hierarchical network meta-analysis models to address sparsity of events and differing treatment classifications with regard to adverse outcomes","volume":"33","author":"Warren","year":"2014","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0161|cit161","doi-asserted-by":"crossref","DOI":"10.1002\/9781119942986","volume-title":"Evidence synthesis in decision making in healthcare","author":"Welton","year":"2012"},{"key":"10.1002\/14651858.CD013210.pub2-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nu\u00f1ez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD013210.pub2-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013210","article-title":"Interventions for maintenance of surgically-induced remission in Crohn\u2019s disease: a network meta-analysis","author":"Clegg","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013210.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T21:29:17Z","timestamp":1702330157000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013210.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":163,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013210.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]}}}